(Q70061642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

P Smyth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

S Pringle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

G Jackson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A R Lorimer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

613-618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00615226

8 October 2019

exact match

0 references

cites work

The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension

1 reference

12 December 2020

A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension

1 reference

12 December 2020

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man

1 reference

12 December 2020

Effect of alpha- and beta-blocker therapy on blood lipids: European experience

1 reference

12 December 2020

Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension

1 reference

12 December 2020

Antihypertensive treatment and serum lipoproteins

1 reference

12 December 2020

Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart Failure

1 reference

12 December 2020

A multicenter trial of doxazosin in West Germany

1 reference

12 December 2020

Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]

1 reference

12 December 2020

Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in Man

1 reference

12 December 2020

Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins

1 reference

12 December 2020

A pharmacodynamic and pharmacokinetic assessment of a new alpha- adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00615226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2971549%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference